Advanced Biomed
web2Advanced Biomed is a holding company developing artificial intelligence software for checking f...
About
Advanced Biomed is a holding company developing artificial intelligence software for checking financial information against underlying documents and rules through its Hong Kong technology subsidiary. Its principal product, FinTruth, is designed to verify financial analyses and AI-generated content and produce traceable results for enterprise users. The company acquired Acellent Technologies in April 2026 and shifted away from its former biotechnology business. It sold its previous subsidiaries engaged in microfluidic technology and cancer screening development during 2025 and 2026. FinTruth remains at an early commercialization stage, with pilot discussions underway and no customer revenue from the product reported in its latest annual filing.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Advanced Biomed profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy